
Gonzalo Díaz Soto
@gonzalodiazsoto
Endocrinology, diabetes & metabolism.
Hospital Clínico Universitario de Valladolid. Valladolid University. Spain
/ὁρμᾶν/
ID: 1319616797700726788
23-10-2020 12:29:07
508 Tweet
876 Followers
559 Following

Work smarter, not harder! A low renin with concurrent use of ACEi/ARB is almost certainly some shade of Primary Aldosteronism. Either way, aldosterone-directed therapy is very likely to provide major clinical benefits ahajournals.org/eprint/TUS6CGX… Cheng-Hsuan Tsai









Preliminary analysis of AI-based thyroid nodule evaluation in a nonsubspecialist setting-Just published! Probably a small series, but with meaningful implication for initial screening in a previously unexplored clinical context Congrats! Pablo Fernández link.springer.com/article/10.100…

Nuevo estudio de nuestro equipo sobre IA en evaluación del nódulo tiroideo por ecografía. Pablo Fernández Lucía egomezhoyos D de luis Gonzalo Díaz Soto link.springer.com/article/10.100…


¡¡Enhorabuena Pablo Fernández !! Premio Mejor Residente HCUV. Estamos muy orgullosos de haberte acompañado en tu camino como residente, y recuerda: Ahora empieza la aventura… Gonzalo Díaz Soto


Abro hilo sobre la nueva convocatoria #GRS de investigación en Salud JCYL . Todos queremos una investigación de calidad que se generalize, pero hay decisiones en esta GRS que van directamente en contra de esta idea. 1/10




Entertaining and Informative Symposium on Updates in Management of Differentiated Thyroid Cancer with Drs Mike Tuttle, Julie Sosa and Trevor Angell! Looking forward to seeing the new ATA guidelines, just accepted for publication! #ENDO2025 Endocrine Society @JASosaMD Trevor E Angell MD




Slower titration of semaglutide (5 "clicks" on the pen dial/week if tolerated) in patients with T2DM improves adherence (2% vs 19% dropout) & nausea with equal A1c/weight outcomes vs standard dosing. ADA Professional Publications Read Here➡️ diabetesjournals.org/care/lookup/do…


Beyond glycemic metrics: RW benefits of connected insulin pens in #T1D. Read now the most recent publication from the Diabetes Technology Working Group SED Diabetes New insulin pens enhanced glycemic control, mitigated GV and improve #PROS diabetesresearchclinicalpractice.com/article/S0168-…